UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Optimizing the treatment of metastatic castration-resistant prostate cancer: a Latin America perspective

Medical oncology (Northwood, London, England), 2018-04, Vol.35 (4), p.56-11, Article 56

2018

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

The New England journal of medicine, 2023-11, Vol.389 (19), p.1778-1789

2023

Link zum Volltext

Verfügbarkeit prüfen

Experience of bipolar androgen therapy (BAT) in Argentinian oncology centres

Ecancermedicalscience, 2022, Vol.16, p.1480-1480

2022

Link zum Volltext

Verfügbarkeit prüfen

Enhancing Clinical Decision-Making in LATAM through Virtual Genitourinary Tumour Boards

Société internationale d'urologie journal, 2023-11, Vol.4 (6), p.454-457

2023

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer in Latin America: Challenges and Recommendations

Cancer Control, 2020-01, Vol.27 (1), p.1073274820915720-1073274820915720

2020

Link zum Volltext

Verfügbarkeit prüfen

Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)

JCO global oncology, 2021-04, Vol.7 (7), p.559-571

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

European urology, 2020-04, Vol.77 (4), p.508-547

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-world genetic testing patterns in metastatic prostate cancer in Latin American (LATAM) population

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17055-e17055

2023

Link zum Volltext

Verfügbarkeit prüfen

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

European urology, 2023-03, Vol.83 (3), p.267-293

2023

Link zum Volltext

Verfügbarkeit prüfen

PARP inhibitors as a radiosensitizer: a future promising approach in prostate cancer?

Ecancermedicalscience, 2021, Vol.15, p.ed118

2021

Link zum Volltext

Verfügbarkeit prüfen

High doses of chemotherapy and autologous hematopoietic stem cell transplantation in patients with relapsed/refractory testicular germ cell tumors: Multicenter real-world experience in Argentina

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.508-508

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes and patient (pt) profiles in REASSURE: An observational study of radium-223 (Ra-223) in metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.32-32

2020

Link zum Volltext

Verfügbarkeit prüfen

What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021

European urology, 2022-07, Vol.82 (1), p.6-11

2022

Link zum Volltext

Verfügbarkeit prüfen

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

Cancer immunology, immunotherapy, 2024-04, Vol.73 (6), p.106

2024

Link zum Volltext

Verfügbarkeit prüfen

Institutional retrospective analysis of definitive chemo-radiotherapeutic treatment (QRT) in locally advanced cervical cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e17016-e17016

2017

Link zum Volltext

Verfügbarkeit prüfen

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Cancer Immunology, Immunotherapy, 2023-11, Vol.72 (11), p.3665-3682

2023

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11]

European urology, 2022-07, Vol.82 (1), p.e18-e19

2022

Link zum Volltext

Verfügbarkeit prüfen

Intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT): A risk group with heterogeneous behavior

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.145-145

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancerResearch in context

EClinicalMedicine, 2023-06, Vol.60, p.101993

2023

Link zum Volltext

Verfügbarkeit prüfen

High Doses of Chemotherapy and Autologous Hematopoietic STEM Cell Transplantation in Patients with Relapsed/Refractory Testicular GERM Cell Tumors. Multicenter Real-World Experience in Argentina

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S306-S307

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer

EClinicalMedicine, 2023-06, Vol.60, p.101993-101993, Article 101993

2023

Link zum Volltext

Verfügbarkeit prüfen

Patient (pt) characteristics and treatment patterns in the radium (Ra)-223 REASSURE observational study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5042-5042

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Oncology
(8)
Humans
(6)
Metastasis
(6)
Prostate Cancer
(6)
Male
(5)
Patients
(5)
Chemotherapy
(4)
Metastases
(4)
Prostatic Neoplasms, Castration-Resistant - Pathology
(4)
Survival
(4)
Medicine
(3)
Medicine & Public Health
(3)
Radium-223
(3)
Urology & Nephrology
(3)
Urothelial Carcinoma
(3)
Androgen Antagonists - Therapeutic Use
(2)
Androgens
(2)
Cancer Research
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Optimizing the treatment of metastatic castration-resistant prostate cancer: a Latin America perspective

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

Experience of bipolar androgen therapy (BAT) in Argentinian oncology centres

Enhancing Clinical Decision-Making in LATAM through Virtual Genitourinary Tumour Boards

Prostate Cancer in Latin America: Challenges and Recommendations

Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

Real-world genetic testing patterns in metastatic prostate cancer in Latin American (LATAM) population

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

PARP inhibitors as a radiosensitizer: a future promising approach in prostate cancer?

High doses of chemotherapy and autologous hematopoietic stem cell transplantation in patients with relapsed/refractory testicular germ cell tumors: Multicenter real-world experience in Argentina

Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial

Clinicopathological characterization, FGFR alteration prevalence, and outcomes of locally advanced or metastatic urothelial cancer in Latin America (LACOG 1518)

Clinical outcomes and patient (pt) profiles in REASSURE: An observational study of radium-223 (Ra-223) in metastatic castration-resistant prostate cancer (mCRPC)

What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

Institutional retrospective analysis of definitive chemo-radiotherapeutic treatment (QRT) in locally advanced cervical cancer

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11]

Intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT): A risk group with heterogeneous behavior

Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancerResearch in context

High Doses of Chemotherapy and Autologous Hematopoietic STEM Cell Transplantation in Patients with Relapsed/Refractory Testicular GERM Cell Tumors. Multicenter Real-World Experience in Argentina

Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer

Patient (pt) characteristics and treatment patterns in the radium (Ra)-223 REASSURE observational study

Suchergebnisse filtern